Don't work for Pharma Account - Recensione dipendente - Account Team presso Epsilon

1,0
15 gen 2022
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

-Hard to think of pros especially for one of the pharma accounts

Svantaggi

-The employees on the Pharma account hired without much relevant experience -Super high turnover -Highers many young people who are hungry to put in many hours for little pay -Many things last minute or poor communication

Esplora altre recensioni su Epsilon

5,0
8 giu 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Work culture, people that work here, and hybrid work.

Svantaggi

Compensation and of course corporate politics.

1,0
26 mar 2026
Dipendente anonimo
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

There are no "Pros". Company is getting driven into the ground, quickly. Unlimited FTO - sure nice if you EVER get to take time off

Svantaggi

Employees have been strung along last year (2025), told there would be Merit Increases -- should have been in March 2025 (didn't happen); then we're told it would be in July 2025 (didn't happen); then we're told would have a meeting in Sept 2025; there was a All Hands call and we we're told ONLY Top Performers would get a BONUS, and no one else. Then, in Jan 2026, there was money Allocated for FULL Merit Increases for April 2026. NO Senior Mgnt Communication. It's the end of March 2026 and we are told from our Managers (NOT Senior Mgnt) that there would NOT be any Merit Increases, supposedly "tabled" until July 2026. Time will tell.

7
avatar
Risposta di Epsilon
3mo
Thank you for your feedback. Your insights will be shared with leadership as we work to improve.
Vedi recensioni per: Utile|Valutazione|Data|Tutto